Stine Trolle

Stine Trolle is a Senior Advisor at Lægemiddelstyrelsen (Danish Medicines Agency) since September 2024, focusing on the implementation of the EU Health Technology Assessment (HTA) Regulation to enhance the availability of medicines and medical devices. Previously, Stine served as a Senior Specialist in the Drug and Therapeutic Committee at Region Hovedstadens Apotek from January 2019 to September 2024, where responsibilities included developing medicine recommendations and implementing treatment guidelines. Additionally, Stine has held consultant roles at the World Health Organization, conducting investigations related to antimicrobial resistance and market assessments of antibiotics. Earlier experience includes research at the Access to Medicine Foundation and a Regulatory Assistant position at Ferring Pharmaceuticals. Stine holds a Master of Science in Pharmacy from the University of Copenhagen, supplemented by studies in International Public Health at Boston University, and a Bachelor of Science in Pharmacy from the University of Copenhagen.